1-Sulfonyl-3-amino-1
Journal
ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658
Informations de publication
Date de publication:
14 Nov 2023
14 Nov 2023
Historique:
received:
17
08
2023
revised:
10
10
2023
accepted:
12
10
2023
medline:
29
11
2023
pubmed:
29
11
2023
entrez:
29
11
2023
Statut:
epublish
Résumé
Yellow fever virus (YFV) transmitted by infected mosquitoes causes an acute viral disease for which there are no approved small-molecule therapeutics. Our recently developed machine learning models for YFV inhibitors led to the selection of a new pyrazolesulfonamide derivative
Identifiants
pubmed: 38024733
doi: 10.1021/acsomega.3c06106
pmc: PMC10653066
doi:
Types de publication
Journal Article
Langues
eng
Pagination
42951-42965Informations de copyright
© 2023 The Authors. Published by American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare the following competing financial interest(s): S.E. is owner, A.C.P, T.J. and T.R.L. are employees of Collaborations Pharmaceuticals, Inc. Others have no competing interests. A provisional patent on this work has been submitted.
Références
Lancet. 2016 May 28;387(10034):2165-6
pubmed: 27229187
Antimicrob Agents Chemother. 2009 Jan;53(1):202-9
pubmed: 18955536
Antimicrob Agents Chemother. 2014 Nov;58(11):6607-14
pubmed: 25155605
Chem Biol Drug Des. 2019 Apr;93(4):430-437
pubmed: 30381875
Mutat Res. 1985 Jun;147(3):65-78
pubmed: 3923333
PLoS One. 2016 Feb 04;11(2):e0148181
pubmed: 26845440
Nat Rev Drug Discov. 2011 Mar;10(3):188-95
pubmed: 21358738
Bioorg Med Chem. 2013 Jun 1;21(11):3127-37
pubmed: 23608107
Curr Infect Dis Rep. 2017 Mar;19(3):14
pubmed: 28275932
Front Microbiol. 2018 Dec 18;9:3121
pubmed: 30619195
J Chem Inf Model. 2021 Aug 23;61(8):3804-3813
pubmed: 34286575
Expert Rev Anti Infect Ther. 2019 Jul;17(7):467-470
pubmed: 31216912
Mol Pharm. 2022 Feb 7;19(2):674-689
pubmed: 34964633
Trop Dis Travel Med Vaccines. 2023 Jan 15;9(1):1
pubmed: 36707912
Chem Asian J. 2019 Nov 18;14(22):3962-3968
pubmed: 31389664
J Virol. 2016 Nov 14;90(23):10774-10788
pubmed: 27654301
Mem Inst Oswaldo Cruz. 2018 Sep 03;113(10):e180278
pubmed: 30427974
J Med Chem. 2005 Nov 3;48(22):6997-7004
pubmed: 16250658
J Health Econ. 2016 May;47:20-33
pubmed: 26928437
PLoS Negl Trop Dis. 2022 Jan 24;16(1):e0009937
pubmed: 35073319
PLoS Negl Trop Dis. 2015 Jun 26;9(6):e0003878
pubmed: 26114876
Elife. 2021 Mar 16;10:
pubmed: 33722340
Nat Rev Drug Discov. 2017 Aug;16(8):565-586
pubmed: 28473729
Trop Doct. 2017 Apr;47(2):92-96
pubmed: 28424031
PLoS Negl Trop Dis. 2019 Jan 30;13(1):e0007072
pubmed: 30699122
Mol Pharm. 2017 Dec 4;14(12):4462-4475
pubmed: 29096442
Yale J Biol Med. 2010 Jun;83(2):77-85
pubmed: 20589188
Microorganisms. 2022 Oct 22;10(11):
pubmed: 36363688
J Clin Virol. 2015 Mar;64:160-73
pubmed: 25453327
Front Virol. 2022;2:
pubmed: 37461745
F1000Res. 2015 Oct 20;4:1091
pubmed: 26834994
J Med Chem. 2023 May 11;66(9):6193-6217
pubmed: 37130343
Biol Direct. 2015 Mar 25;10:10
pubmed: 25880749
Emerg Infect Dis. 2019 Aug;25(8):1567-1570
pubmed: 31310221
Antiviral Res. 2007 Feb;73(2):140-6
pubmed: 17049380
J Virol. 1998 Jan;72(1):73-83
pubmed: 9420202
Mol Pharm. 2018 Oct 1;15(10):4346-4360
pubmed: 29672063
Bioorg Med Chem. 2015 Aug 15;23(16):5210-7
pubmed: 25573118
Drug Discov Today. 2018 Jun;23(6):1241-1250
pubmed: 29366762
Cell. 2020 Oct 29;183(3):837
pubmed: 33125895
Bioorg Med Chem Lett. 2015 May 1;25(9):1827-30
pubmed: 25866241
J Med Chem. 2018 Jul 26;61(14):6247-6260
pubmed: 29906396
Expert Opin Drug Discov. 2017 Apr;12(4):407-425
pubmed: 28164720
Nat Biotechnol. 2019 Sep;37(9):1038-1040
pubmed: 31477924
PLoS Pathog. 2022 Jan 21;18(1):e1010271
pubmed: 35061864